{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-017810","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2025-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.914539+00:00","generated_at":"2026-05-18T09:28:48.800755+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lantern Pharma enters $15.53M ATM equity offering agreement with ThinkEquity","bullets":["ATM Sales Agreement allows sale of up to $15,530,000 in common stock through ThinkEquity as agent.","Agent commission set at 3.0% of gross proceeds; sales at prevailing market prices on Nasdaq.","Company has no obligation to sell any shares; agreement terminates upon full sale or earlier termination.","Offering registered under existing S-3 shelf (File No. 333-279718); prospectus supplement filed July 3, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-017810","json":"https://secwatch.observer/filing/0001641172-25-017810.json","markdown":"https://secwatch.observer/filing/0001641172-25-017810.md","text":"https://secwatch.observer/filing/0001641172-25-017810.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000164117225017810/0001641172-25-017810-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000164117225017810/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:28:48.800755+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}